読み込み中
BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human connective tissue matrix for homologous use; and American Amnion, a human connective tissue matrix for homologous use. The company was formerly known as Caribbean International Holdings Inc. and changed its name to BioStem Technologies, Inc. in August 2014. BioStem Technologies, Inc. was incorporated in 2006 and is based in Fort Lauderdale, Florida.
前日終値
$2.47
−$0.17 · -6.44%
時間外
$2.47
$0.00 · 0.00%
10月9日 19:30 ET
日中の時刻はETです。市場データは遅延する場合があります。
BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human connective tissue matrix for homologous use; and American Amnion, a human connective tissue matrix for homologous use. The company was formerly known as Caribbean International Holdings Inc. and changed its name to BioStem Technologies, Inc. in August 2014. BioStem Technologies, Inc. was incorporated in 2006 and is based in Fort Lauderdale, Florida.
日中レンジ
現在 $2.47
52週レンジ
現在 $2.47
日中の時刻はETです。市場データは遅延する場合があります。
BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human connective tissue matrix for homologous use; and American Amnion, a human connective tissue matrix for homologous use. The company was formerly known as Caribbean International Holdings Inc. and changed its name to BioStem Technologies, Inc. in August 2014. BioStem Technologies, Inc. was incorporated in 2006 and is based in Fort Lauderdale, Florida.
日中レンジ
現在 $2.47
52週レンジ
現在 $2.47
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 4748.2万 USD | 3.02億 USD | 1668.54万 USD | 687.52万 USD | 434.08万 USD |
| 売上原価 | 326.25万 USD | 1374.58万 USD | 126.18万 USD | 88.18万 USD | 147.48万 USD |
| 粗利益 | 4421.95万 USD | 2.88億 USD | 1542.37万 USD | 599.34万 USD | 286.61万 USD |
| 研究開発 | 708.61万 USD | 191.1万 USD | 34.2万 USD | 22.48万 USD | 11.96万 USD |
| 販売・一般管理 | 3782.26万 USD | 2.55億 USD | 2263.28万 USD | 1020.68万 USD | 418.79万 USD |
| 営業費用 | 4490.87万 USD | 2.57億 USD | 2320.38万 USD | 1067.5万 USD | 447.18万 USD |
| 受取利息 | 41.38万 USD | — | — | — | — |
| 支払利息 | — | 58.72万 USD | 70.03万 USD | 46.82万 USD | 52.59万 USD |
| 減価償却費と償却費 | 38.1万 USD | 29.32万 USD | 22.9万 USD | 22.25万 USD | 28.38万 USD |
| 営業利益 | −68.91万 USD | 3120.06万 USD | −777.9万 USD | −468.15万 USD | −160.57万 USD |
| 純利益 | −658.09万 USD | 3188.43万 USD | −848.3万 USD | −719.29万 USD | −144.54万 USD |
会社概要が更新されました 2026年10月10日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$7.00
上昇余地（183.40%）AIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
